InventionMed S.A. (WSE:INM)

Poland · Delayed Price · Currency is PLN

0.1090

+0.0030 (2.83%)

Last updated: Nov 3, 2026, 12:13 PM CET

Market Cap	22.10M -25.6%
Revenue (ttm)	2.90M +44.3%
Net Income	1.05M
EPS	0.01
Shares Out	202.79M
PE Ratio	21.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,721
Open	0.1095
Previous Close	0.1060
Day's Range	0.1070 - 0.1095
52-Week Range	0.0972 - 0.1465
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 16, 2026

About InventionMed

InventionMed S.A. focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. The company flagship project is TutorDerm, a simulator and an application that lets users perform actions necessary to treat specific dermatological diseases. It also offers double immersion, and Virtual Syringe, a training equipment for specialists in clinical and aesthetic dermatology. In addition, the company provides education and training services, as well as simulators of medical ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2012

Employees 5

Stock Exchange Warsaw Stock Exchange

Ticker Symbol INM

Full Company Profile

Financial Performance

In 2025, InventionMed's revenue was 3.17 million, an increase of 1041.56% compared to the previous year's 277,760. Losses were -749,410, -82.99% less than in 2024.

Financial Statements